Equity Overview
Price & Market Data
Price: $16.48
Daily Change: +$0.56 / 3.40%
Range: $15.68 - $16.87
Market Cap: $432,608,224
Volume: 44,868
Performance Metrics
1 Week: 3.00%
1 Month: 21.35%
3 Months: 10.09%
6 Months: 40.37%
1 Year: 119.7%
YTD: 30.48%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.